FDA cleared the twiist Loop Algorithm from Deka Research and Development Corp. on Oct 15, 2026 under K262576, a traditional 510(k). The device falls under product code QJI, Interoperable Automated Glycemic Controller, regulated at 21 CFR 862.1356 as a Class 2 device. The review panel was Clinical Chemistry.
FDA logged the submission as received on Jul 27, 2026. The decision came 80 days later, inside the 90 FDA-day goal for a 510(k).
Deka Research and Development Corp. has 2 other decisions in the tracker over the last 12 months: K261672 (twiist Automated Insulin Delivery (AID) System), K261530 (iiSure Infusion Set).